0001593968-24-000714.txt : 20240520 0001593968-24-000714.hdr.sgml : 20240520 20240520180127 ACCESSION NUMBER: 0001593968-24-000714 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240516 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chang David D CENTRAL INDEX KEY: 0001611024 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 24966272 MAIL ADDRESS: STREET 1: C/O ALLOGENE THERAPEUTICS, INC. STREET 2: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 primary_01.xml PRIMARY DOCUMENT X0508 4 2024-05-16 0001737287 Allogene Therapeutics, Inc. ALLO 0001611024 Chang David D 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true true President and CEO false Common Stock 2024-05-16 4 A false 344828 2.9 A 4810106 D Common Stock 1201108 I See footnote Common Stock 856044 I See footnote Common Stock 856044 I See footnote These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering. Securities held in the name of the Chang 2006 Family Trust Securities held in the name of the JEC 2019 Trust dated October 1, 2019. Securities held in the name of the RTC 2019 Trust dated October 1, 2019. /s/Earl Douglas, Attorney-in-Fact 2024-05-20